Best Telehealth Clinics in Alabama (2026)

Alabama has one of the most restrictive telehealth environments for controlled substance prescribing in the country. The state requires an in-person visit within 12 months before a telehealth provider can prescribe controlled substances, codified at Ala. Code § 34-24-703. This in-person requirement survived the COVID emergency and was not repealed or softened by subsequent legislation.

In February 2025, the Alabama Board of Medical Examiners (BME) issued guidance stating that telehealth is not considered a valid modality for initiating or managing testosterone replacement therapy. This is one of the most explicit state-level positions against telehealth TRT in the country. The BME's position is that TRT requires hands-on physical examination, including assessment of testicular size and prostate evaluation, which cannot be performed via video.

This guidance is the primary reason TRT Nation explicitly excludes Alabama (along with AK, AR, MO, and HI). Other national telehealth TRT providers that claim "all 50 states" coverage may technically serve Alabama but face significant compliance risk under the BME's stated position.

Alabama is an active IMLC member, but IMLC licensure does not waive the 12-month in-person requirement or the BME's TRT-specific guidance. Out-of-state physicians with IMLC-expedited Alabama licenses face the same restrictions as in-state providers.

Alabama does not have telehealth coverage parity legislation for commercial insurance. Medicaid telehealth coverage was expanded during COVID and partially maintained through administrative action, but there is no comprehensive parity statute comparable to other states. Alabama Medicaid does not cover GLP-1 receptor agonists for obesity — only for diabetes indications.

GLP-1 compounding is subject to additional scrutiny in Alabama. The Alabama Board of Pharmacy has issued guidance requiring compounded GLP-1 medications to meet pharmaceutical-grade standards, and the board has investigated pharmacies dispensing compounded semaglutide. This creates supply chain uncertainty for patients using compounded GLP-1s from telehealth platforms.

The Alabama PDMP (ALPMP) is mandatory under Ala. Code § 20-2-214. Providers must check the PDMP before prescribing Schedule II through V controlled substances. Electronic prescribing is required for Schedule II substances.

Alabama has 5.0 million residents. Provider availability for TRT is among the lowest in the country due to the BME's February 2025 guidance against telehealth TRT and the 12-month in-person requirement under § 34-24-703.

TRT Nation explicitly excludes Alabama. All-50-state providers like Maximus ($100/mo) and Hone Health ($25/mo) technically list Alabama, but the BME's position creates legal uncertainty for any telehealth-only TRT platform operating in the state. BraverX ($129/mo), PeterMD ($99/mo), and DudeMeds ($77/mo) list "Most US states" — verify Alabama coverage directly before enrolling.

GLP-1 availability is moderate. National providers like Embody, SkinnyRx, DirectMeds, Zealthy, Remedy Meds, GobyMeds, Sesame Care, and Mochi Health serve Alabama. The Board of Pharmacy's scrutiny of compounded GLP-1s may affect availability from platforms that rely on compounding pharmacies. Alabama Medicaid does not cover GLP-1s for weight loss.

HRT, hair loss, and ED providers with national coverage generally serve Alabama. These treatments do not face the same BME restrictions as TRT since they involve non-controlled or differently scheduled medications.

Enhance MD excludes Alabama from its 11-state exclusion list, consistent with the state's restrictive controlled substance telehealth environment.

TRT pricing from providers that claim to serve Alabama: DudeMeds $77/mo ($1,124/year), PeterMD $99/mo ($1,188/year), Maximus $100/mo ($1,300/year), BraverX $129/mo ($1,548/year). TRT Nation ($99/mo) does not serve Alabama. Verify actual availability before enrolling — the BME's position may cause providers to decline Alabama patients during intake.

GLP-1 ranges from $99/mo to $399/mo. Median is $179/mo. Alabama Medicaid does not cover GLP-1s for obesity — only for diabetes. Patients seeking GLP-1s for weight management must pay the full out-of-pocket cost. The Board of Pharmacy's compounding scrutiny may limit the availability of lower-cost compounded options.

Alabama does not tax prescription medications. The state sales tax is 4% (plus local taxes up to 7.5% combined in some areas) but Rx drugs are exempt. Alabama has a progressive income tax with rates from 2% to 5%.

HRT: Midi Health (insurance), PlushCare ($20/mo), Evernow ($35/mo). ED: Hims $17/mo to MEDVi $119/mo.

The 12-month in-person visit requirement adds indirect cost for TRT patients who must see a local provider before starting or continuing telehealth testosterone therapy. Factor in the cost of an in-person visit ($150 to $400) when calculating total TRT costs in Alabama.

TRT (testosterone replacement therapy)

Alabama is one of the most restrictive states for telehealth TRT. The BME's February 2025 guidance states telehealth is not valid for TRT initiation or management. Ala. Code § 34-24-703 requires an in-person visit within 12 months for controlled substance prescribing. TRT Nation excludes AL. Providers claiming "all 50 states" face compliance risk. Both the in-person requirement and BME guidance survive the federal DEA waiver.

GLP-1 weight loss

No specific state law prohibits GLP-1 telehealth prescribing. The Alabama Board of Pharmacy has scrutinized compounded GLP-1 pharmacies, which may affect supply. Alabama Medicaid does not cover GLP-1s for obesity. Federal FDA compounding rules apply.

HRT (hormone replacement therapy)

HRT follows standard federal prescribing rules in Alabama. The BME's TRT guidance is specific to testosterone and does not appear to extend to estrogen/progesterone HRT. No additional state restrictions identified for female HRT.

Hair loss

Hair loss treatment follows standard federal prescribing rules in Alabama. No additional state restrictions apply.

ED (erectile dysfunction)

ED treatment follows standard federal prescribing rules in Alabama. No additional state restrictions apply.

Peptides

Peptide therapy follows standard federal rules in Alabama. The 12-month in-person requirement applies to controlled peptide prescriptions. Non-controlled peptides have fewer restrictions but may face Board of Pharmacy scrutiny similar to compounded GLP-1s.